Hydroxypinacolone Retinoate (HPR) Encyclopedia — Scientific Background

What Is Hydroxypinacolone Retinoate?

Hydroxypinacolone retinoate (CAS 893412-73-2), also known as HPR or Granactive Retinoid, is a cosmetic-grade ester of all-trans retinoic acid (ATRA) with the molecular formula C₂₆H₃₈O₃ and a molecular weight of 398.58 g/mol. It is a yellow crystalline solid that is oil-soluble and is typically supplied in solution form for cosmetic applications. HPR is a member of the retinoid family—vitamin A derivatives that are widely recognized as effective treatments for photoaging, promoting epidermal turnover and dermal collagen production.

The Direct Receptor Binding Advantage

HPR's most distinctive feature is its ability to bind directly to retinoic acid receptors without undergoing metabolic decomposition into a more biologically active form. Retinol, the cosmetic form of vitamin A, requires two enzymatic conversion steps (to retinaldehyde and then to retinoic acid) to become active. In contrast, HPR is a direct-acting retinoid that possesses innate retinoic acid activity. This direct mechanism of action is responsible for HPR's superior stability, reduced irritation potential, and more predictable dose-response profile compared to conventional retinoids.

Mechanisms of Action

Retinoic Acid Receptor Binding — RAR/RXR Activation

HPR acts as a direct activator of retinoic acid receptors. Research indicates that 9-cis HPR selectively activates retinoic acid receptor α (RARα) and retinoid X receptor α (RXRα). This selective receptor activation profile contributes to HPR's anti-aging efficacy with reduced irritation compared to non-selective retinoids. By directly binding to these nuclear receptors, HPR regulates gene expression related to collagen synthesis, elastin production, and epidermal differentiation.

Collagen and Elastin Synthesis

A synergistic complex containing HPR significantly increased expression levels of type I collagen genes col1a1b and col1a2, as well as the elastin gene Elna, by 217%, 184%, and 290%, respectively (P<0.05), surpassing the effects of its individual components. Mechanistic studies have demonstrated that HPR combined with retinol synergistically activates TGF-β/Smad signaling and enhances extracellular matrix gene expression compared to retinol alone. Skins treated with HPR significantly increased pro-collagen production compared with untreated control skins, and was comparable to ATRA.

Anti-Inflammatory Activity

The HPR-containing complex exhibited a more pronounced reduction of neutrophil aggregation compared to retinol (−25% vs. +1008%, P<0.05), demonstrating significant anti-inflammatory effects. This anti-inflammatory activity contributes to HPR's favorable tolerability profile and makes it particularly suitable for acne-prone and sensitive skin.

Melanogenesis Inhibition

Research on 9-cis HPR has demonstrated that it inhibits melanogenesis by downregulating melanogenesis-related genes, including tyrosinase (Tyr), making it effective for hyperpigmentation and uneven skin tone.

The Bioavailability Challenge

Despite its therapeutic potential, native HPR presents significant formulation challenges. The compound has poor stability in certain solvent systems, particularly in highly hygroscopic solutions where HPR has been found to be unstable. Stability studies have shown that at 45°C, only 74% of uncoated HPR remained after 12 weeks, and it is recommended to avoid heat above 60°C during formulation. Additionally, HPR faces limitations in skin penetration and delivery efficiency, as its effectiveness is hampered by instability and poor skin penetration.

These limitations have driven the development of advanced delivery systems, including nanoliposomes and nanoemulsions. A nanoliposome platform co-delivering HPR and carnosine was developed to overcome these challenges and enhance epidermal/dermal delivery. Hyaluronic acid-modified nanoemulsions have also been developed for targeted transdermal delivery of HPR.

liposomal Hydroxypinacolone Retinoate

Liposomal encapsulation of HPR provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the HPR molecule, forming a nanoscale vesicle that enhances stability, skin penetration, and cellular uptake. This delivery system:

• Enhances stability by protecting HPR from heat, light, and oxidative degradation

• Improves epidermal/dermal delivery through nanoliposome platform technology

• Reduces irritation potential by minimizing direct skin contact

• Provides sustained release for prolonged retinoid receptor activation

• Achieves comprehensive pro-regenerative, anti-inflammatory, antioxidative, and anti-glycation effects

The nanoliposome platform represents a promising nano-delivery strategy for advanced anti-aging skincare, demonstrating comprehensive pro-regenerative, anti-inflammatory, antioxidative, and anti-glycation effects.

Clinical Evidence

Mild Photoaging — 8-Week Clinical Study

An 8-week study in middle-aged Chinese women with mild photoaging evaluated a serum containing retinol, HPR, peptides, and silybin. The serum significantly improved wrinkles, elasticity, hydration, barrier function, and pigmentation with excellent tolerability. Mechanistic studies demonstrated that retinol + HPR synergistically activated TGF-β/Smad signaling and enhanced extracellular matrix gene expression compared to retinol alone.

Split-Face Comparison — HPR vs. Retinol

A single-blind, split-face design clinical trial involving 31 women compared 0.03% 9-cis HPR with 0.3% retinol applied to opposite sides of the face every evening for four weeks. Daily 0.03% 9-cis HPR produced comparable or greater improvements in several measures, including wrinkles. For participants new to retinoids, a half-dose application was recommended during the first week.

UV-Induced Photoaging — 10-Week Study

A 10-week UV irradiation study evaluated 0.03% and 0.1% concentrations of 9-cis HPR for mitigating UV-induced photoaging. The study demonstrated that 9-cis HPR reduced erythema and inhibited melanogenesis by downregulating melanogenesis-related genes.

Manufacturer Clinical Data

Manufacturer Grant Industries cites 12-week studies in 30–50 women demonstrating improvements in texture, fine wrinkles, and hyperpigmentation at 2–5% HPR concentrations.

Safety and Regulatory

HPR has a favorable safety profile. A modified 21-day cumulative skin irritation test in humans confirmed that HPR is non-corrosive and there is little to no skin irritation associated with dermal use of HPR. The TGA has noted the safety of HPR up to concentrations of 1 per cent. A 24-hour closed patch test with 30 healthy volunteers found that the HPR complex had less irritation versus retinol.

Regulatory Status:

• United States — HPR is listed in the FDA Global Substance Registration System with UNII code NJ3V2F02E1 and CAS Registry No. 893412-73-2. It is regulated as a cosmetic ingredient.

• European Union — HPR is registered as a cosmetic ingredient under INCI name "Hydroxypinacolone Retinoate."

• Australia — TGA has assessed HPR and reported that it is non-corrosive with little to no skin irritation associated with dermal use.

• Global Standards — HPR is available with HACCP, HALAL, KOSHER, ISO9001, and ISO22000 certifications. Chinese cosmetic testing standard T/GDCA 015-2022 specifies HPLC and HPLC-MS/MS methods for determination of HPR in cosmetics.

Precautions: AAD 2024, SEGO 2023, and AEDV 2024 classify all topical retinoids (including HPR) as unwanted in pregnancy and lactation. Avoid using HPR with other strong exfoliants such as AHAs to prevent irritation. Benzoyl peroxide oxidizes retinoids, making them inactive. Use sun protection during HPR use.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

1499$/KG

1299$/KG